Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study (Q44371716)

2 December 2017

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study (English)

1 reference

2 December 2017

0 references

1 reference

7

Mihai Gheorghiade

1 reference

2 December 2017

6

Robert M Califf

1 reference

2 December 2017

Christopher M O'Connor

series ordinal

8

object named as

Christopher M O'Connor

1 reference

2 December 2017

1

G Michael Felker

1 reference

2 December 2017

4

Jeffrey D Leimberger

1 reference

2 December 2017

2

Raymond L Benza

1 reference

2 December 2017

OPTIME-CHF Investigators

series ordinal

9

object named as

OPTIME-CHF Investigators

1 reference

2 December 2017

A Bleakley Chandler

3

1 reference

2 December 2017

Michael S Cuffe

series ordinal

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of the American College of Cardiology

2 December 2017

1 reference

2 December 2017

41

1 reference

2 December 2017

6

1 reference

2 December 2017

997-1003

1 reference

Relation between gender, etiology and survival in patients with symptomatic heart failure.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Etiology and response to drug treatment in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Inotropic stimulation by dobutamine increases left ventricular regional function at the expense of metabolism in hibernating myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Ten-year trends in hospital care for congestive heart failure: improved outcomes and increased use of resources

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Chronic heart failure in the United States: a manifestation of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Adrenergic regulation of myocardial apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

A standardized definition of ischemic cardiomyopathy for use in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902968-6

7 January 2021

10.1016/S0735-1097(02)02968-6

Identifiers

DOI

1 reference

2 December 2017

1 reference